{"companyId":283143,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"KORU Medical Systems, Inc.","headOfficeLocation":"100 Corporate Drive Mahwah, New Jersey 07430 United States","presidentName":"Adam Kalbermatten","companySummary":null,"stockCode":"KRMD","currency":"USD","capital":null,"sales":41,"employees":73,"employeesConsolidated":null,"humanCheck":false,"domains":["korumedical.com"],"businessContents":["development, manufacturing, and commercialization of innovative and patient-centric large volume sub","Pharma Services and Clinical Trials","Syringe Infusion Drivers","Precision Flow Rate Tubing™","HigH-Flo Subcutaneous Safety Needle Sets™","Freedom System"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://investors.korumedical.com/news-events/press-releases/detail/195/koru-medical-systems-announces-20-fourth-quarter-and-full-year-2025-revenue-growth-positive-adjusted-ebitda-and-initiates-full-year-2026-guidance","scoreAbout":-5,"scoreBusiness":69,"scoreGroup":-10,"scoreCustomer":-10}]}